Quantitative Insight into the Design of Compounds Recognized by the L‐Type Amino Acid Transporter 1 (LAT1)

L ‐Type amino acid transporter 1 (LAT1) is a transmembrane protein expressed abundantly at the blood–brain barrier (BBB), where it ensures the transport of hydrophobic acids from the blood to the brain. Due to its unique substrate specificity and high expression at the BBB, LAT1 is an intriguing target for carrier‐mediated transport of drugs into the brain. In this study, a comparative molecular field analysis (CoMFA) model with considerable statistical quality (Q²=0.53, R²=0.75, Q² SE=0.77, R² SE=0.57) and good external predictivity (CCC=0.91) was generated. The model was used to guide the synthesis of eight new prodrugs whose affinity for LAT1 was tested by using an in situ rat brain perfusion technique. This resulted in the creation of a novel LAT1 prodrug with L ‐tryptophan as the promoiety; it also provided a better understanding of the molecular features of LAT1‐targeted high‐affinity prodrugs, as well as their promoiety and parent drug. The results obtained will be beneficial in the rational design of novel LAT1‐binding prodrugs and other compounds that bind to LAT1.     

Efficient Synthesis of Phenylacetate and 2-Phenylethanol by Modular Cascade Biocatalysis

The green and sustainable synthesis of chemicals from renewable feedstocks by a biotransformation approach has gained increasing attention in recent years. In this work, we developed enzymatic cascades to efficiently convert l -phenylalanine into 2-phenylethanol (2-PE) and phenylacetic acid (PAA), l -tyrosine into tyrosol (p-hydroxyphenylethanol, p-HPE) and p-hydroxyphenylacetic acid (p-HPAA). The enzymatic cascade was cast into an aromatic aldehyde formation module, followed by an aldehyde reduction module, or aldehyde oxidation module, to achieve one-pot biotransformation by using recombinant Escherichia coli. Biotransformation of 50 mM l -Phe produced 6.76 g/L PAA with more than 99 % conversion and 5.95 g/L of 2-PE with 97 % conversion. The bioconversion efficiencies of p-HPAA and p-HPE from l -Tyr reached to 88 and 94 %, respectively. In addition, m-fluoro-phenylalanine was further employed as an unnatural aromatic amino acid substrate to obtain m-fluoro-phenylacetic acid; >96 % conversion was achieved. Our results thus demonstrated high-yielding and potential industrial synthesis of above aromatic compounds by one-pot cascade biocatalysis.     

L-Type Amino Acid Transporter 1 Regulates Cancer Stemness and the Expression of Programmed Cell Death 1 Ligand 1 in Lung Cancer Cells

The l-type amino acid transporter 1 (LAT1) is a membranous transporter that transports neutral amino acids for cells and is dysregulated in various types of cancer. Here, we first observed increased LAT1 expression in pemetrexed-resistant non-small cell lung cancer (NSCLC) cells with high cancer stem cell (CSC) activity, and its mRNA expression level was associated with shorter overall survival in the lung adenocarcinoma dataset of the Cancer Genome Atlas database. The inhibition of LAT1 by a small molecule inhibitor, JPH203, or by RNA interference led to a significant reduction in tumorsphere formation and the downregulation of several cancer stemness genes in NSCLC cells through decreased AKT serine/threonine kinase (AKT)/mammalian target of rapamycin (mTOR) activation. The treatment of the cell-permeable leucine derivative promoted AKT/mTOR phosphorylation and reversed the inhibitory effect of JPH203 in the reduction of CSC activity in pemetrexed-resistant lung cancer cells. Furthermore, we observed that LAT1 silencing caused the downregulation of programmed cell death 1 ligand 1 (PD-L1) on lung cancer cells. The PD-L1⁺/LAT1⁺ subpopulation of NSCLC cells displayed great CSC activity with increased expression of several cancer stemness genes. These data suggest that LAT1 inhibitors can serve as anti-CSC agents and could be used in combination with immune checkpoint inhibitors in lung cancer therapy.     

Role of Catechol Structure in the Adsorption and Transformation Reactions of <Emphasis Type="SmallCaps">l</Emphasis>-D<Emphasis Type="SmallCaps">opa</Emphasis> in Soils

3-(3′,4′-Dihydroxyphenyl)-l-alanine (l-DOPA), which is synthesized in velvet bean (Mucuna pruriens), inhibits plant growth. The concentration of l-DOPA in soil is reduced by adsorption and transformation reactions, which can result in the reduction of its plant-growth-inhibitory activity. To determine which part of the l-DOPA structure is involved in the adsorption and soil transformation reactions, we compared the kinetics of l-DOPA disappearance in a volcanic ash soil with that of l-phenylalanine (3-phenyl-l-alanine) and l-tyrosine (3-(4′-hydroxyphenyl)-l-alanine), compounds that are similar in structure to l-DOPA but do not have a catechol (o-dihydroxybenzene) moiety. l-Phenylalanine and l-tyrosine were not adsorbed and transformed in the soil at equilibrium pH values between 4 and 7. These results suggest that the adsorption and transformation reactions of l-DOPA in the soil involve the catechol moiety and not the amino and carboxylic acid groups, which are common to all three compounds. Like l-DOPA, (+)-catechin, another allelochemical that contains a catechol moiety, underwent adsorption and soil transformation reactions. Thus, we concluded that the concentrations of allelochemicals bearing a catechol moiety in soils will decrease rapidly owing to adsorption and transformation reactions, and this decrease will be faster in soils with a high pH value or high adsorption ability. Owing to this decrease in concentration, allelopathic phenomena may not occur.     

Development of Sesamol Carbamate-L-Phenylalanine Prodrug Targeting L-Type Amino Acid Transporter1 (LAT1) as a Potential Antiproliferative Agent against Melanoma

Sesamol is a compound reported to have anti-melanogenesis and anti-melanoma actions. Sesamol, however, has low intracellular drug concentration and fast excretion, which can limit its benefits in the clinic. To overcome this drawback and increase intracellular delivery of sesamol into the target melanoma, research has focused on L-type amino acid transporter 1 (LAT1)-mediated prodrug delivery into melanoma cells. The sesamol prodrug was designed by conjugating sesamol with L-phenylalanine at the para position with a carbamate bond. LAT1 targeting was evaluated vis-à-vis a competitive [¹⁴C]-leucine uptake inhibition. The sesamol prodrug has a higher [¹⁴C]-leucine uptake inhibition than sesamol in human LAT1-transfected HEK293 cells. Moreover, the sesamol prodrug was taken up by LAT1-mediated transport into SK-MEL-2 cells more effectively than sesamol. The sesamol prodrug underwent complete hydrolysis, releasing the active sesamol at 72 h, which significantly exerted its cytotoxicity (IC₅₀ of 29.3 µM) against SK-MEL-cells more than sesamol alone. Taken together, the strategy for LAT1-mediated prodrug delivery has utility for the selective uptake of sesamol, thereby increasing its intracellular concentration and antiproliferation activity, targeting melanoma SK-MEL-2 cells that overexpress the LAT1 protein. The sesamol prodrug thus warrants further evaluation in an in vivo model.     

Controlling Enzymatic Activity by Modulating the Oligomerization State via Chemical Rescue and Optical Control

Selective switching of enzymatic activity has been a longstanding goal in synthetic biology. Drastic changes in activity upon mutational manipulation of the oligomerization state of enzymes have frequently been reported in the literature, but scarcely exploited for switching. Using geranylgeranylglyceryl phosphate synthase as a model, we demonstrate that catalytic activity can be efficiently controlled by exogenous modulation of the association state. We introduced a lysine-to-cysteine mutation, leading to the breakdown of the active hexamer into dimers with impaired catalytic efficiency. Addition of bromoethylamine chemically rescued the enzyme by restoring hexamerization and activity. As an alternative method, we incorporated the photosensitive unnatural amino acid o-nitrobenzyl-O-tyrosine (ONBY) into the hexamerization interface. This again led to inactive dimers, but the hexameric state and activity could be recovered by UV-light induced cleavage of ONBY. For both approaches, we obtained switching factors greater than 350-fold, which compares favorably with previously reported activity changes that were caused by site-directed mutagenesis.     

Overexpression of miR-375 and L-type Amino Acid Transporter 1 in Pheochromocytoma and Their Molecular and Functional Implications

Pheochromocytoma (Pheo) is a tumor derived from chromaffin cells. It can be studied using 18F-dihydroxyphenylalanine (DOPA)—positron emission tomography (PET) due to its overexpression of L-type amino acid transporters (LAT1 and LAT2). The oncogenic pathways involved are still poorly understood. This study examined the relationship between ¹⁸F-DOPA-PET uptake and LAT1 expression, and we explored the role of miR-375 and putative target genes. A consecutive series of 58 Pheo patients were retrospectively analyzed, performing ¹⁸F-DOPA-PET in 32/58 patients. Real-time quantitative PCR was used to assess the expression of LAT1, LAT2, phenylethanolamine N-methyltransferase (PNMT), miR-375, and the major components of the Hippo and Wingless/Integrated pathways. Principal germline mutations associated with hereditary Pheo were also studied. Pheo tissues had significantly higher LAT1, LAT2, and PNMT mRNA levels than normal adrenal tissues. MiR-375 was strongly overexpressed. Yes-associated protein 1 and tankyrase 1 were upregulated, while beta-catenin, axin2, monocarboxylate transporter 8, and Frizzled 8 were downregulated. A positive relationship was found between ¹⁸F-DOPA-PET SUV mean and LAT1 gene expression and for 24 h-urinary norepinephrine and LAT1. This is the first experimental evidence of ¹⁸F-DOPA uptake correlating with LAT1 overexpression. We also demonstrated miR-375 overexpression and downregulated (Wnt) signaling and identified the Hippo pathway as a new potentially oncogenic feature of Pheo.     

Chemical Methods for N- and O-Sulfation of Small Molecules,Amino Acids and Peptides

Sulfation of the amino acid residues of proteins is a significant post-translational modification, the functions of which are yet to be fully understood. Current sulfation methods are limited mainly to O-tyrosine (sY), which requires negatively charged species around the desired amino acid residue and a specific sulfotransferase enzyme. Alternatively, for solid-phase peptide synthesis, a de novo protected sY is required. Therefore, synthetic routes that go beyond O-sulfation are required. We have developed a novel route to N-sulfamation and can dial-in/out O-sulfation (without S-sulfurothiolation), mimicking the initiation step of the ping-pong sulfation mechanism identified in structural biology. This rapid, low-temperature and non-racemising method is applicable to a range of amines, amides, amino acids, and peptide sequences.     

Probing the Outstanding Local Hydrophobicity Increases in Peptide Sequences Induced by Incorporation of Trifluoromethylated Amino Acids

In order to achieve accurate determination of the local hydrophobicity increases in peptide sequences produced by incorporation of trifluoromethylated amino acids (TfmAAs), the chromatographic hydrophobicity indexes (?₀) of three series of tripeptides containing three unnatural trifluoromethylated amino acids have been measured and compared with those of their non‐fluorinated analogues. The hydrophobic contribution of each fluorinated amino acid was quantified by varying the position and the protection of (R)‐ and (S)‐α‐trifluoromethylalanine (TfmAla), (R)‐trifluoromethylcysteine (TfmCys), and (S)‐trifluoromethionine (TFM) in a short peptide sequence. As a general trend, strong increases in hydrophobicity were precisely measured, even exceeding the high hydrophobic contribution of the natural amino acid isoleucine. This study validates the incorporation of trifluoromethylated amino acids into peptide sequences as a rational strategy for the fine‐tuning of hydrophobic peptide–protein interactions.     

Inducible versus constitutive PI 227687 soybean resistance to mexican bean beetle,Epilachna varivestis

Contrary to constitutive resistance, inducible resistance to Mexican bean beetle (MBB) (Epilachna varivestis) herbivory in PI 227687 soybean leaves was positively correlated with total phenolic content and temporally unique, increasedl-phenylalanine ammonia-lyase (PAL) andl-tyrosine ammonia-lyase (TAL) activities. Initial expression of the induced resistance was localized at or near the site of herbivory. Systemic parameters of the induced resistance also were observed. Inducible MBB resistance in PI 227687 soybeans apparently involves increased phenylpropanoid metabolism.     

Assessment of the Phytotoxic Potential of <Emphasis Type="Italic">m</Emphasis>-Tyrosine in Laboratory Soil Bioassays

The significance of soil-allelochemical interactions was addressed in this paper through studies conducted with m-tyrosine, an amino acid analogue and a potent plant growth inhibitor, in a series of laboratory assays performed in field soil or growth media. The studies were performed as a basis for further evaluation of m-tyrosine activity in field soils containing living plant roots. Here, we examined the role of common soil amendments, including ammonium nitrate fertilizer and activated carbon, in overcoming plant growth inhibition in soils in a laboratory setting by using lettuce as a sensitive indicator of plant toxicity. The phytotoxicity of m-tyrosine was not influenced significantly by soil N amendment; however, when significant amounts of activated carbon were added to the soil medium, growth inhibition in treated lettuce seedlings was strongly reduced. Soil texture did not influence the bioavailability or activity of m-tyrosine, as activity in high organic growth media was similar to that of sand and soil mixtures. Similar to other purported allelochemicals, soil persistence of m-tyrosine was limited, with a predicted half life of less than 1 day in soil in a controlled laboratory setting. Rapid degradation of this molecule likely was due to microbial activity but degradation did not appear to be influenced significantly by soil N amendment. Given the observed activity of m-tyrosine in soil and growth media on seedling growth, potential may exist for development of m-tyrosine as a soil applied herbicide if formulations can be stabilized under soil conditions.     

Behavioral responses of crayfish (Orconectes virilis andOrconectes rusticus) to chemical feeding stimulants

We conducted two experiments to assess how chemical stimuli affect feeding behavior, grooming, and walking in the crayfishesOrconectes virilis andOrconectes rusticus. In the first experiment,O. virilis was tested with 29 amino acids; in the second experiment,0. rusticus was tested with 12 amino acids, 13 additional single compounds, and two six-compound mixtures. InO. virilis, the following amino acids, in order of potency, elicited feeding movements:l-isoleucine, glycine, hydroxy-l-proline,l-glutamate,l-valine, and B-alanine. Grooming increased in response tol-phenylalanine,l-tryptophan,l-tyrosine,l-leucine,l-methionine, and D-aspartate. InO. rusticus, both mixtures and the following single compounds, in order of potency, elicited feeding movements: cellobiose, sucrose, glycine, maltose, glycogen, nicotinic acid methyl ester, putrescine, andl-glutamate. Grooming increased in response to putrescine only, and walking increased in response to glycogen only. The responsiveness of these crayfishes to a wide variety of chemicals may reflect the omnivorous foraging habits of these crustaceans.     

An Aminocaprolactam Racemase from Ochrobactrum anthropi with Promiscuous Amino Acid Ester Racemase Activity

The kinetic resolution of amino acid esters (AAEs) is a useful synthetic strategy for the preparation of single‐enantiomer amino acids. The development of an enzymatic dynamic kinetic resolution (DKR) process for AAEs, which would give a theoretical yield of 100 % of the enantiopure product, would require an amino acid ester racemase (AAER); however, no such enzyme has been described. We have identified low AAER activity of 15 U mg^?1 in a homologue of a PLP‐dependent α‐amino ?‐caprolactam racemase (ACLR) from Ochrobactrum anthropi. We have determined the structure of this enzyme, OaACLR, to a resolution of 1.87 Å and, by using structure‐guided saturation mutagenesis, in combination with a colorimetric screen for AAER activity, we have identified a mutant, L293C, in which the promiscuous AAER activity of this enzyme towards l ‐phenylalanine methyl ester is improved 3.7‐fold.     

Synthesis of amino acid‐based polymers having metronidazole moiety and study of their controlled release in vitro

A new polymeric drug carrier system using amino acid‐based polymers was developed. Amino acid‐based polymers with controlled molar mass and narrow molecular weight distribution have been synthesized by reversible addition‐fragmentation chain transfer polymerization of four amino acid‐carrying monomers having different chirality and hydrophilicity. Metronidazole (MTZ) was immobilized onto the amino acid‐based polymers, and the release profiles of the polymer‐MTZ adducts were investigated in phosphate buffer solutions (pH = 2.0, 7.4, and 8.5). The model drug was released by the hydrolysis of the ester group, and the release rate and behavior of the polymeric prodrugs strongly depended on the configuration of the amino acid‐based polymers‐MTZ adducts and the pH of the release media. The release kinetics was determined using the Higuchi and Korsmeyer equations, which revealed the release mechanism of the polymeric prodrugs. © 2012 Wiley Periodicals, Inc. J. Appl. Polym. Sci., 2013     

Amino Acid Transporter LAT1 (SLC7A5) Mediates MeHg-Induced Oxidative Stress Defense in the Human Placental Cell Line HTR-8/SVneo

The placental barrier can protect the fetus from contact with harmful substances. The potent neurotoxin methylmercury (MeHg), however, is very efficiently transported across the placenta. Our previous data suggested that L-type amino acid transporter (LAT)1 is involved in placental MeHg uptake, accepting MeHg-L-cysteine conjugates as substrate due to structural similarity to methionine. The aim of the present study was to investigate the antioxidant defense of placental cells to MeHg exposure and the role of LAT1 in this response. When trophoblast-derived HTR-8/SVneo cells were LAT1 depleted by siRNA-mediated knockdown, they accumulated less MeHg. However, they were more susceptible to MeHg-induced toxicity. This was evidenced in decreased cell viability at a usually noncytotoxic concentration of 0.03 µM MeHg (~6 µg/L). Treatment with ≥0.3 µM MeHg increased cytotoxicity, apoptosis rate, and oxidative stress of HTR-8/SVneo cells. These effects were enhanced under LAT1 knockdown. Reduced cell number was seen when MeHg-exposed cells were cultured in medium low in cysteine, a constituent of the tripeptide glutathione (GSH). Because LAT1-deficient HTR-8/SVneo cells have lower GSH levels than control cells (independent of MeHg treatment), we conclude that LAT1 is essential for de novo synthesis of GSH, required to counteract oxidative stress. Genetic predisposition to decreased LAT1 function combined with MeHg exposure could increase the risk of placental damage.     

Isoindoline-Based Nitroxides as Bioresistant Spin Labels for Protein Labeling through Cysteines and Alkyne-Bearing Noncanonical Amino Acids

Electron paramagnetic resonance (EPR) spectroscopy in combination with site-directed spin labeling (SDSL) is a powerful tool in protein structural research. Nitroxides are highly suitable spin labeling reagents, but suffer from limited stability, particularly in the cellular environment. Herein we present the synthesis of a maleimide- and an azide-modified tetraethyl-shielded isoindoline-based nitroxide (M- and Az-TEIO) for labeling of cysteines or the noncanonical amino acid para-ethynyl-l -phenylalanine (pENF). We demonstrate the high stability of TEIO site-specifically attached to the protein thioredoxin (TRX) against reduction in prokaryotic and eukaryotic environments, and conduct double electron–electron resonance (DEER) measurements. We further generate a rotamer library for the new residue pENF-Az-TEIO that affords a distance distribution that is in agreement with the measured distribution.     

Active‐Site Engineering Expands the Substrate Profile of the Basidiomycete l‐Tryptophan Decarboxylase CsTDC

Aromatic l ‐amino acid decarboxylases (AADCs) catalyze the release of CO₂ from proteinogenic and non‐proteinogenic l ‐amino acid substrates and are involved in pathways that biosynthesize neurotransmitters or bioactive natural products. In contrast to AADCs from animals and plants, fungal AADCs have received very little attention. Here, we report on the in vitro characterization of heterologously produced Ceriporiopsis subvermispora AADC, now referred to as CsTDC, which is the first characterized basidiomycete AADC. This study identified the enzyme as a decarboxylase that is strictly specific for l ‐tryptophan and 5‐hydroxy‐l ‐tryptophan. The tdc gene was subjected to saturation mutagenesis so as to vary the key active site residue, Gly351. Aliphatic amino acid residues, l ‐serine, or l ‐threonine at position 351 added l ‐tyrosine and 3,4‐dihydroxy‐l ‐phenylalanine (l ‐DOPA) decarboxylase activity while retaining stereospecificity and l ‐tryptophan decarboxylase activity.     

Synthesis and Antiviral Evaluation of TriPPPro‐AbacavirTP,TriPPPro‐CarbovirTP,and Their 1′,2′‐cis‐Disubstituted Analogues

Herein we describe the synthesis of lipophilic triphosphate prodrugs of abacavir, carbovir, and their 1′,2′‐cis‐substituted carbocyclic analogues. The 1′,2′‐cis‐carbocyclic nucleosides were prepared by starting from enantiomerically pure (1R,2S)‐2‐((benzyloxy)methyl)cyclopent‐3‐en‐1‐ol by a microwave‐assisted Mitsunobu‐type reaction with 2‐amino‐6‐chloropurine. All four nucleoside analogues were prepared from their 2‐amino‐6‐chloropurine precursors. The nucleosides were converted into their corresponding nucleoside triphosphate prodrugs (TriPPPro approach) by application of the H‐phosphonate route. The TriPPPro compounds were hydrolyzed in different media, in which the formation of nucleoside triphosphates was proven. While the TriPPPro compounds of abacavir and carbovir showed increased antiviral activity over their parent nucleoside, the TriPPPro compounds of the 1′,2′‐cis‐substituted analogues as well as their parent nucleosides proved to be inactive against HIV.     

Reactive extraction of d,l-phenylalanine with trioctyl-methyl-ammonium chloride (TOMAC) as a carrier—III. Equilibrium and mass transfer investigations

The partition coefficient and the equilibrium constants are evaluated for the reactive extraction of d, l-phenylalanine from the aqueous phase into xylene/TOMAC (liquid ion exchanger) at different amino acid and carrier concentration. Also, the interfacial mass transport of the reactive extraction process is investigated, and the mass transfer coefficients of the components are identified. The influence of coextraction of buffer- and/or OH⁻-ions is discussed.     

The Effects of Mutations on Protein Function: A Comparative Study of Three Databases of Mutations in Humans

Single-nucleotide mutations (SNPs) in protein-coding regions of the human genome are a major factor in determining human variation in health and disease. Here, we analyze the amino acid changes and functional effects due to non-synonymous SNPs. Three databases were used: (i) Variation – mutations found in the general human population; (ii) Cosmic – mutations found in cancer cells; and (iii) Pathogenic – a curated subset of mutations in Variation that are associated with diseases. The distributions of amino acid changes in these datasets were analyzed. It is shown that mutations in the Pathogenic dataset, in particular, tend to introduce order-promoting residues. The effects of the mutations in these datasets were also studied using the program Polyphen-2, which predicts the functional impact of non-synonymous mutations. In order to evaluate the significance of these predicted effects, we compared them to those due to the same amino acid replacements introduced at other positions in the same proteins as a control. A mutation can be deleterious because the amino acid change is drastic (for example a change from hydrophobic residue to hydrophilic residue) or because of its location in the protein. We found that, on both counts, mutations in the Variation dataset tend to be less deleterious than randomly expected whereas mutations in the Pathogenic dataset tend to be more deleterious than their control mutations. The mutations in the Cosmic dataset are found to be more deleterious than those in its control set but less than those in Pathogenic.